Discover how new global guidelines aim to combat the rising threat of Candida infections with updated treatments and ...

NLS Pharmaceutics Ltd. (NASDAQ: NLSP), a Swiss clinical-stage biopharmaceutical company focused on developing innovative ...

Try foods, drinks, and plant compounds, like ginger, that counteract histamine reactions. Find a complete list of ...

After years of research into xenotransplantation, the field is at a turning point—yet risks and ethical issues remain ...

An experimental stem cell therapy reversed corneal damage in half of the participants from a recent clinical trial.

The following is a summary of "Nanobodies targeting the tumor microenvironment and their formulation as nanomedicines," ...

(NASDAQ: ADTX) ("Aditxt" or the "Company"), a social innovation platform dedicated to accelerating promising health innovations, today provided an update on its subsidiary, Adimune, Inc., (“Adimune”) ...

Fintel reports that on March 6, 2025, Wedbush initiated coverage of Tourmaline Bio (NasdaqGS:TRML) with a Outperform ...

Dr Pietro Canetta describes a case from early in his career, highlighting the importance of early, aggressive treatment for long-term remission and improved outcomes.

Aditxt (NASDAQ: ADTX) provided an update on its subsidiary, Adimune, Inc., and the progress of ADI-100, an investigational gene therapy targeting aut ...

A rare kidney transplant, the surgery was performed on a patient with chronic kidney disease that began with a hypertension ...